Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis
Clinical trial NCT07517575 · RECRUITING
Trial details
- NCT number
- NCT07517575
- Sponsor
- R-Pharm International, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-17
- Primary completion
- 2026-09-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.